"Older Adults with ASD: The Consequences of Aging." Insights from a series of special interest group meetings held at the International Society for Autism Research 2016-2017.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101300021 Publication Model: Print Cited Medium: Print ISSN: 1750-9467 (Print) NLM ISO Abbreviation: Res Autism Spectr Disord Subsets: PubMed not MEDLINE

Original Publication: Amsterdam : Elsevier

A special interest group (SIG) entitled "Older Adults with ASD: The Consequences of Aging" was held at the International Society for Autism Research (INSAR) annual meetings in 2016 and 2017. The SIG and subsequent meetings brought together, for the first time, international delegates who were members of the autistic community, researchers, practitioners and service providers. Based on aging autism research that is already underway in UK, Europe, Australia and North America, discussions focussed on conceptualising the parameters of aging when referring to autism, and the measures that are appropriate to use with older adults when considering diagnostic assessment, cognitive factors and quality of life in older age. Thus, the aim of this SIG was to progress the research agenda on current and future directions for autism research in the context of aging. A global issue on how to define 'aging' when referring to ASD was at the forefront of discussions. The 'aging' concept can in principle refer to all developmental transitions. However, in this paper we focus on the cognitive and physical changes that take place from mid-life onwards. Accordingly, it was agreed that aging and ASD research should focus on adults over the age of 50 years, given the high rates of co-occurring physical and mental health concerns and increased risk of premature death in some individuals. Moreover, very little is known about the cognitive change, care needs and outcomes of autistic adults beyond this age. Discussions on the topics of diagnostic and cognitive assessments, and of quality of life and well-being were explored through shared knowledge about which measures are currently being used and which background questions should be asked to obtain comprehensive and informative developmental and medical histories. Accordingly, a survey was completed by SIG delegates who were representatives of international research groups across four continents, and who are currently conducting studies with older autistic adults. Considerable overlap was identified across different research groups in measures of both autism and quality of life, which pointed to combining data and shared learnings as the logical next step. Regarding the background questions that were asked, the different research groups covered similar topics but the groups differed in the way these questions were formulated when working with autistic adults across a range of cognitive abilities. It became clear that continued input from individuals on the autism spectrum is important to ensure that questionnaires used in ongoing and future are accessible and understandable for people across the whole autistic spectrum, including those with limited verbal abilities.

J Child Psychol Psychiatry. 2014 Jan;55(1):49-58. (PMID: 23848399)
Med Clin North Am. 2014 Sep;98(5):1169-91. (PMID: 25134878)
Autism Res. 2008 Dec;1(6):354-63. (PMID: 19360690)
Autism. 2014 Oct;18(7):756-70. (PMID: 24789871)
Neurotherapeutics. 2010 Jul;7(3):320-7. (PMID: 20643385)
Autism. 2019 Feb;23(2):287-305. (PMID: 29439585)
J Autism Dev Disord. 2018 Jun;48(6):2038-2051. (PMID: 29349671)
J Child Psychol Psychiatry. 2004 Feb;45(2):212-29. (PMID: 14982237)
Gerontology. 2012;58(1):70-8. (PMID: 21865667)
Trends Cogn Sci. 2006 Mar;10(3):131-8. (PMID: 16460992)
Autism. 2018 Oct;22(7):774-783. (PMID: 28805071)
J Exp Psychol Gen. 2003 Dec;132(4):566-94. (PMID: 14640849)
Autism. 2016 Jul;20(5):515-6. (PMID: 27141078)
Psychol Med. 1998 May;28(3):551-8. (PMID: 9626712)
J Autism Dev Disord. 2011 May;41(5):589-96. (PMID: 20697795)
J Clin Child Adolesc Psychol. 2014;43(5):828-43. (PMID: 25216048)
Autism. 2016 May;20(4):442-62. (PMID: 26134030)
J Autism Dev Disord. 2008 Sep;38(8):1485-98. (PMID: 18302014)
J Autism Dev Disord. 2010 Oct;40(10):1171-8. (PMID: 20182784)
PLoS One. 2014 Oct 10;9(10):e109946. (PMID: 25303222)
Neurosci Biobehav Rev. 2012 Apr;36(4):1292-313. (PMID: 22353426)
Nature. 2010 Mar 25;464(7288):529-35. (PMID: 20336135)
J Autism Dev Disord. 2012 Sep;42(9):1998-9. (PMID: 22183423)
J Autism Dev Disord. 2003 Aug;33(4):427-33. (PMID: 12959421)
J Autism Dev Disord. 2008 Sep;38(8):1555-66. (PMID: 18302013)
Qual Life Res. 2004 Mar;13(2):299-310. (PMID: 15085902)
Med Hypotheses. 2014 Sep;83(3):337-42. (PMID: 25047996)
Autism. 2008 Jul;12(4):403-14. (PMID: 18579647)
J Intellect Disabil Res. 2006 Oct;50(Pt 10):768-77. (PMID: 16961706)
J Neurodev Disord. 2015;7(1):29. (PMID: 26322138)
Autism Adulthood. 2019 Mar 1;1(1):27-36. (PMID: 36600693)
J Autism Dev Disord. 2006 Feb;36(2):263-70. (PMID: 16586157)
Neurosci Biobehav Rev. 2012 Aug;36(7):1729-39. (PMID: 22155274)
J Psychosom Res. 1994 Jan;38(1):23-32. (PMID: 8126686)
Autism Res. 2017 Dec;10(12):1945-1959. (PMID: 28940848)
J Autism Dev Disord. 2017 Oct;47(10):3204-3219. (PMID: 28730417)
J Am Acad Child Adolesc Psychiatry. 2013 Jun;52(6):572-81.e1. (PMID: 23702446)
Front Psychol. 2016 Oct 20;7:1601. (PMID: 27812340)
Cereb Cortex. 2016 Sep;26(9):3851-65. (PMID: 26315689)
Appl Neuropsychol. 2010 Oct;17(4):289-98. (PMID: 21154043)
J Autism Dev Disord. 2018 May;48(5):1596-1611. (PMID: 29188584)
Cereb Cortex. 2005 Nov;15(11):1676-89. (PMID: 15703252)
J Autism Dev Disord. 2017 Jun;47(6):1830-1837. (PMID: 28343343)
J Neurodev Disord. 2013 Sep 25;5(1):27. (PMID: 24066979)
Gerontol Geriatr Educ. 2019 Jul-Sep;40(3):322-338. (PMID: 27749163)
J Gen Intern Med. 2016 Jan;31(1):77-84. (PMID: 26361965)
Cogn Psychol. 2014 Mar;69:25-45. (PMID: 24423632)
Arch Gen Psychiatry. 2011 May;68(5):459-65. (PMID: 21536975)
J Am Acad Child Adolesc Psychiatry. 2015 Jan;54(1):11-24. (PMID: 25524786)
Neuropsychology. 2010 Jan;24(1):9-34. (PMID: 20063944)
Psychol Rev. 1996 Jul;103(3):403-28. (PMID: 8759042)
Psychol Aging. 2009 Jun;24(2):338-48. (PMID: 19485652)
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2015;22(6):679-92. (PMID: 25808599)
J Gerontol B Psychol Sci Soc Sci. 2017 Jan;72(1):1-6. (PMID: 27974471)
Br J Psychiatry. 2016 Mar;208(3):232-8. (PMID: 26541693)
BMC Psychiatry. 2009 Jun 10;9:35. (PMID: 19515234)
Int J Geriatr Psychiatry. 2012 Feb;27(2):109-18. (PMID: 21538534)
Health Qual Life Outcomes. 2007 Nov 27;5:63. (PMID: 18042300)
Autism. 2015 Oct;19(7):814-23. (PMID: 25911091)
Nat Rev Neurosci. 2004 Feb;5(2):87-96. (PMID: 14735112)
Autism Res. 2016 Jun;9(6):666-76. (PMID: 26333004)
Autism. 2015 Feb;19(2):158-67. (PMID: 24443331)
J Am Acad Child Adolesc Psychiatry. 2012 Jun;51(6):622-31. (PMID: 22632621)
Neuropsychology. 2010 Mar;24(2):222-243. (PMID: 20230116)
Autism. 2017 Aug;21(6):643-645. (PMID: 28749233)
J Autism Dev Disord. 2001 Feb;31(1):5-17. (PMID: 11439754)
J Autism Dev Disord. 2016 Nov;46(11):3469-3480. (PMID: 27549589)
Psychol Bull. 2012 May;138(3):458-96. (PMID: 22409507)
Can J Psychiatry. 2012 May;57(5):275-83. (PMID: 22546059)
Ment Retard Dev Disabil Res Rev. 2004;10(4):234-47. (PMID: 15666341)
Ann Pharmacother. 2003 Dec;37(12):1800-3. (PMID: 14632599)
Autism Res. 2018 Aug;11(8):1138-1147. (PMID: 29734506)
Autism Res. 2017 Jul;10(7):1215-1220. (PMID: 28266790)
J Autism Dev Disord. 2016 Jun;46(6):1916-1930. (PMID: 26861713)
J Gerontol B Psychol Sci Soc Sci. 2017 Jan;72(1):51-60. (PMID: 27836922)
Psychol Bull. 2011 Sep;137(5):753-84. (PMID: 21463028)
Cortex. 2017 Jan;86:186-204. (PMID: 27251123)

Keywords: Aging; Autism spectrum disorder; Diagnosis; Measurement; Quality of life

Date Created: 20190706 Latest Revision: 20231012

20231215

PMC6559228

10.1016/j.rasd.2018.08.007

31275429